癌症幸存者的中心敏感化及其临床影响:最新技术
Tomohiko Nishigami1, Masahiro Manfuku2,3, Astrid Lahousse4,5,6,7
1Department of Physical Therapy, Faculty of Health and Welfare, Prefectural University of Hiroshima, Hiroshima 723-0053, Japan.
Journal of clinical medicine
|July 29, 2023
概括
癌症疼痛影响了近一半的幸存者,并且通常没有得到足够的治疗. 针对中央敏感化 (CS) 提供了新的希望,但需要对疼痛神经科学教育 (PNE) 等治疗方法进行进一步的研究.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 神经科学是一个神经科学.
背景情况:
- 癌症疼痛影响了47%的治疗后幸存者,并且经常被低估和治疗不足.
- 癌症疼痛管理的复杂性被缺乏对潜在机制的理解所加剧.
- 中枢敏感性 (CS) 越来越被认为是慢性疼痛状况和从急性疼痛过渡到慢性疼痛的关键因素.
研究的目的:
- 审查中央敏感性 (CS) 或中央敏感性综合征与癌症幸存者的疼痛之间的关联.
- 探索针对癌症幸存者疼痛管理的CS治疗方法.
- 突出准确医学在管理CS方面的潜在作用.
主要方法:
- 现有文献的最新审查.
- 分析CS在癌症疼痛机制中的作用.
- 评估目前和新兴的CS治疗策略.
主要成果:
- CS显著影响慢性疼痛状况和癌症患者的急性至慢性疼痛过渡.
- 管理策略应解决维持CS的潜在因素,而不仅仅是组织损伤.
- 疼痛神经科学教育 (PNE) 显示出潜力,但需要进一步研究乳腺癌幸存者的疗效.
结论:
- 癌症疼痛与CS的有效管理需要针对潜在的敏感化过程.
- 疼痛神经科学教育 (PNE) 可能有利于CS的癌症幸存者,但更多的研究是必不可少的.
- 精准医学方法,将治疗量身定制为患者子组,对于有效管理癌症疼痛中的CS至关重要.
相关概念视频
Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
Psychoneuroimmunology: Diabetes and Cancer
47
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
47
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Vaccines
405
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
405
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


